Reconsideration of Antinucleocapsid IgG Antibody as a Marker of SARS-CoV-2 Infection Postvaccination for Mild COVID-19 Patients

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Reconsideration of Antinucleocapsid IgG Antibody as a Marker of SARS-CoV-2 Infection Postvaccination for Mild COVID-19 Patients'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry